definiens: ) . As used herein, shall mean : ( a ) an y consolidation, merger, combination, reorganization or other transaction in which the eq uity holders of LICENSEE in their capacity as such no longer own a majority of the outstanding equity sec urities of LICENSEE ( or its successor ) ; or ( b ) any transaction or series of related transactions in wh ich the outstanding shares of stock or other equity interests of LICENSEE constituting in excess of fif ty percent ( 50 % ) of the voting power of LICENSEE ar e exchanged for or converted into other stock or secu rities, cash, and/or any other property ; or ( c ) a s ale or other disposition of all or substantially all of th e assets of the LICENSEE . For the avoidance of doub t, in no event shall a bona fide equity or debt financing of LICENSEE, a reorganization required to effect a n initial public offering, or the merger of LICENSEE with and into its affiliate Solid Bioscience, LLC, be deemed a for purposes of this A greement . This Section 3.1 ( g ), including all of it s subparts, shall survive any termination of this Agr eement . ” Section 2